Danaher Corp (NYSE:DHR)
$ 234.34 -1.57 (-0.67%) Market Cap: 170.39 Bil Enterprise Value: 181.11 Bil PE Ratio: 45.02 PB Ratio: 3.32 GF Score: 87/100

Danaher Corp at Jefferies Healthcare Conference (Virtual) Transcript

Jun 02, 2021 / 05:00PM GMT
Release Date Price: $214.52 (-1.31%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

Good afternoon. Thanks, everybody, for joining us. Welcome to the Jefferies 2021 Virtual Global Healthcare Conference. I'm Brandon Couillard. I cover the life science tools and diagnostics sector here at the firm. Very pleased to have Danaher with us at the conference this year and joining us for this fireside conversation, CFO, Matt McGrew; and also have Head of IR, Matt Gugino, with us. So thank you both for being here.

Questions & Answers

Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

Matt, wanted to start off with what, I think, is certainly top of mind for investors right now, especially coming out of Abbott's updated guidance yesterday around COVID testing. So want to start with Cepheid. You guys have been pretty upbeat about your PCR testing outlook, talking about Cepheid volumes going from 10 million in the first quarter to 13 million by the end of the year. So kind of 45 million tests for '21. And a similar number, you kind of endorsed for '22. Can you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot